#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3537386	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 12 hrs by mass spectrometry	Macaca fascicularis	1	ALA3526109	organism-based format	Scientific Literature
2.	ALA3537724	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 1 hr by mass spectrometry	Homo sapiens	1	ALA3526109	organism-based format	Scientific Literature
3.	ALA3537725	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 2 hrs by mass spectrometry	Homo sapiens	1	ALA3526109	organism-based format	Scientific Literature
4.	ALA3537726	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 4 hrs by mass spectrometry	Homo sapiens	1	ALA3526109	organism-based format	Scientific Literature
5.	ALA3537727	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 8 hrs by mass spectrometry	Homo sapiens	1	ALA3526109	organism-based format	Scientific Literature
6.	ALA3537728	A	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 12 hrs by mass spectrometry	Homo sapiens	1	ALA3526109	organism-based format	Scientific Literature
7.	ALA3537731	A	Drug level in bile duct-cannulated rat bile treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage by mass spectrometry	Rattus norvegicus	2	ALA3526109	organism-based format	Scientific Literature
8.	ALA3537732	A	Drug level in bile duct-cannulated cynomolgus monkey bile treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage by mass spectrometry	Macaca fascicularis	1	ALA3526109	organism-based format	Scientific Literature
9.	ALA3538186	A	Drug excretion in Sprague-Dawley rat urine treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage by HPLC analysis	Rattus norvegicus	10	ALA3526109	organism-based format	Scientific Literature
10.	ALA3538187	A	Drug excretion in Sprague-Dawley rat feces treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage by HPLC analysis	Rattus norvegicus	15	ALA3526109	organism-based format	Scientific Literature
11.	ALA3538189	A	Drug excretion in cynomolgus monkey urine treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage by HPLC analysis	Macaca fascicularis	13	ALA3526109	organism-based format	Scientific Literature
12.	ALA3538190	A	Drug excretion in cynomolgus monkey feces treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage by HPLC analysis	Macaca fascicularis	15	ALA3526109	organism-based format	Scientific Literature
13.	ALA3538192	A	Drug excretion in human urine treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage by HPLC analysis	Homo sapiens	15	ALA3526109	organism-based format	Scientific Literature
14.	ALA3538193	A	Drug excretion in human feces treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage by HPLC analysis	Homo sapiens	15	ALA3526109	organism-based format	Scientific Literature
15.	ALA3538435	A	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 1 hr by mass spectrometry	Rattus norvegicus	2	ALA3526109	organism-based format	Scientific Literature
16.	ALA3538436	A	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 2 hrs by mass spectrometry	Rattus norvegicus	2	ALA3526109	organism-based format	Scientific Literature
17.	ALA3538437	A	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 6 hrs by mass spectrometry	Rattus norvegicus	2	ALA3526109	organism-based format	Scientific Literature
18.	ALA3538438	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 1 hr by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
19.	ALA3538439	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 2 hrs by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
20.	ALA3538440	A	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 4 hrs by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature